Guardant Health’s MCD test earns FDA breakthrough designation
Guardant Health's Shield multi-cancer detection (MCD) test has secured the US Food and Drug Administration’s (FDA) breakthrough device designation. The post Guardant Health’s MCD test earns FDA breakthrough designation appeared first on Medical Device Network.
Guardant Health's Shield multi-cancer detection (MCD) test has secured the US Food and Drug Administration’s (FDA) breakthrough device designation.
The post Guardant Health’s MCD test earns FDA breakthrough designation appeared first on Medical Device Network.
